Dynavax Historical Balance Sheet
DVAX Stock | USD 12.91 0.25 1.97% |
Trend analysis of Dynavax Technologies balance sheet accounts such as Other Assets of 3 M or Common Stock Shares Outstanding of 135.2 M provides information on Dynavax Technologies' total assets, liabilities, and equity, which is the actual value of Dynavax Technologies to its prevalent stockholders. By breaking down trends over time using Dynavax Technologies balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Dynavax Technologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Dynavax Technologies is a good buy for the upcoming year.
Dynavax Technologies Inventory |
|
Dynavax |
About Dynavax Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Dynavax Technologies at a specified time, usually calculated after every quarter, six months, or one year. Dynavax Technologies Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Dynavax Technologies and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Dynavax currently owns. An asset can also be divided into two categories, current and non-current.
Dynavax Technologies Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Dynavax Technologies assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Dynavax Technologies books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most accounts from Dynavax Technologies' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Dynavax Technologies current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.At this time, Dynavax Technologies' Property Plant And Equipment Net is fairly stable compared to the past year. Net Debt is likely to rise to about 112 M in 2024, despite the fact that Retained Earnings are likely to grow to (884.1 M).
2021 | 2022 | 2023 | 2024 (projected) | Total Liabilities | 816.9M | 404.8M | 375.0M | 393.8M | Other Stockholder Equity | 1.4B | 1.5B | 1.6B | 1.6B |
Dynavax Technologies balance sheet Correlations
Click cells to compare fundamentals
Dynavax Technologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Dynavax Technologies balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 279.1M | 353.3M | 1.0B | 985.9M | 997.1M | 1.0B | |
Total Stockholder Equity | 8.3M | 58.7M | 222.4M | 581.0M | 622.1M | 653.2M | |
Retained Earnings | (1.2B) | (1.3B) | (1.2B) | (924.2M) | (930.6M) | (884.1M) | |
Other Assets | 3.6M | 3.8M | 368.9K | 3.5M | 3.2M | 3.0M | |
Common Stock Shares Outstanding | 72.0M | 100.8M | 133.0M | 150.8M | 128.7M | 135.2M | |
Liabilities And Stockholders Equity | 279.1M | 353.3M | 1.0B | 985.9M | 997.1M | 1.0B | |
Other Stockholder Equity | 1.2B | 1.4B | 1.4B | 1.5B | 1.6B | 1.6B | |
Total Liab | 270.8M | 294.6M | 816.9M | 404.8M | 375.0M | 393.8M | |
Other Current Liab | 43.8M | 32.6M | 201.4M | 143.2M | 52.5M | 30.8M | |
Total Current Liabilities | 53.0M | 77.4M | 556.4M | 150.1M | 62.2M | 58.2M | |
Accounts Payable | 9.3M | 3.3M | 2.6M | 3.2M | 5.2M | 3.1M | |
Cash | 39.9M | 32.1M | 436.2M | 202.0M | 150.3M | 157.8M | |
Short Term Investments | 111.2M | 133.0M | 109.8M | 422.4M | 592.0M | 621.6M | |
Other Current Assets | (8.9M) | 38.6M | 233.4M | 85.6M | 19.0M | 21.4M | |
Common Stock | 84K | 110K | 123K | 128K | 130K | 83.9K | |
Property Plant Equipment | 32.0M | 30.6M | 61.0M | 37.6M | 43.2M | 45.4M | |
Property Plant And Equipment Net | 32.0M | 57.2M | 61.0M | 63.3M | 61.6M | 64.7M | |
Net Debt | 176.6M | 185.8M | (178.8M) | 56.0M | 106.6M | 112.0M | |
Non Current Assets Total | 86.7M | 124.5M | 432.0M | 302.0M | 138.0M | 144.9M | |
Non Currrent Assets Other | 50.1M | 65.1M | 368.9M | 236.7M | 74.3M | 46.8M | |
Cash And Short Term Investments | 151.1M | 165.0M | 546.0M | 624.4M | 742.3M | 779.4M | |
Common Stock Total Equity | 84K | 110K | 123K | 128K | 147.2K | 85.0K | |
Non Current Liabilities Total | 217.7M | 217.2M | 260.5M | 254.8M | 312.8M | 328.5M | |
Property Plant And Equipment Gross | 62.3M | 57.2M | 61.0M | 63.3M | 93.4M | 98.1M | |
Total Current Assets | 192.4M | 228.7M | 607.3M | 683.8M | 859.1M | 902.1M | |
Accumulated Other Comprehensive Income | (2.4M) | 273K | (2.3M) | (5.4M) | (2.1M) | (2.2M) | |
Net Receivables | 8.9M | 22.7M | 131.8M | 147.5M | 44.5M | 46.8M | |
Other Liab | 1.3M | 2.6M | 5.7M | 384K | 345.6K | 328.3K | |
Good Will | 2.1M | 2.3M | 2.1M | 2.0M | 2.1M | 1.8M | |
Inventory | 41.3M | 63.7M | 61.3M | 59.4M | 53.3M | 56.0M | |
Short Long Term Debt Total | 216.4M | 217.8M | 257.4M | 258.0M | 256.9M | 148.9M | |
Long Term Debt | 178.6M | 179.8M | 220.5M | 221.6M | 222.7M | 233.8M | |
Net Tangible Assets | 3.7M | 56.4M | 220.2M | 579.0M | 665.9M | 699.2M | |
Retained Earnings Total Equity | (1.2B) | (1.3B) | (1.2B) | (924.2M) | (831.8M) | (873.4M) | |
Capital Surpluse | 1.2B | 1.4B | 1.4B | 1.5B | 1.7B | 1.1B | |
Non Current Liabilities Other | 39.1M | 37.4M | 5.7M | 33.2M | 74K | 70.3K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Dynavax Stock Analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.